Subchronic toxicity of a fluoroalkylethanol mixture in rats

Drug and Chemical Toxicology

Volumn 28, Issue 2, 2005, Pages 135-158

  Ladics, Gregory S ^a   Stadler, Judith C ^a   Makovec, G Tracey ^a   Everds, Nancy E ^a   Buck, Robert C ^a  

^a DUPONT COMPANY   (United States)

Author keywords

Fluoroalkylethanol mixture; Rat; Subchronic toxicity

Indexed keywords

ALCOHOL DERIVATIVE; FLUORIDE; FLUORINE; METHYLCELLULOSE; SURFACTANT;

AMELOBLAST; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; BLOOD ANALYSIS; BODY WEIGHT; CELL DEGENERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; EVALUATION; FEEDING; FEMALE; LIVER HYPERTROPHY; LIVER WEIGHT; MALE; MICROSCOPY; MORTALITY; NEUROTOXICITY; NONHUMAN; NUTRITIONAL PARAMETERS; RAT; SEX DIFFERENCE; TOOTH DISEASE; TOXICITY TESTING; URINALYSIS;

EID: 17644396365     PISSN: 01480545     EISSN: 15256014     Source Type: Journal    
DOI: 10.1081/DCT-52506     Document Type: Article

References (51)

1. Angmar-Mansson, B., Whitford, G. M. (1984). Enamel fluorosis related to plasma F levels in the rat. Caries Res. 18:25-32.
2. Ashby, J., Brady, A., Elcombe, C. R., Elliott, B. M., Ishmael, J., Odum, J., Tugwood, J. D., Kettle, S., Purchase, I. F. (1994). Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis. Hum. Exp. Toxicol. 13:S1-S117.
3. Bentley, M. A., Calder, I., Elcombe, C., Grasso, P., Stringer, D., Wiegand, H. J. (1993). Hepatic peroxisome proliferation in rodents and its significance for humans. Food Chem. Toxicol. 31:857-907.
4. Biegel, L. B., Hurt, M. E., Frame, S. R., O'Connor, J. C., Cook, J. C. (2001). Mechanisms of extrahepatic tumor induction by peroxisome proliferators in male CD rats. Toxicol. Sci. 60:44-55.
5. Butenhoff, J., Costa, G., Elcombe, C., Farrar, D., Hansen, K., Iwai, H., Jung, R., Kennedy, G. Jr., Lieder, P., Olsen, G., Thomford, P. (2002). Toxicity of ammonium perfluorooctanoate in male cynomolgus monkeys after oral dosing for 6 months. Toxicol. Sci. 69:244-257.
6. Capka, V., Bowers, C., Narvesen, J. N., Rossi, R. F. (2004). Determination of total fluorine in blood at trace concentration levels by the Wickbold decomposition method with direct potentiometric detection. Talanta 64(4):869-878.
7. (1998). Covance study No. 6329-183. In: 104-Week Dietary Carcinogenicity Study with Perfluorooctane Sulfonic Acid Potassium Salt (PFOS, T-6295) in Rats.
8. Draper, N. R., Smith, H. (1981). Applied Regression Analysis. 2nd ed. New York: Wiley.
9. Dunn, O. J. (1964). Multiple comparisons using rank sums. Technometrics 6:241-252.
10. Dunnett, C. W. (1955). A multiple comparison procedure for comparing several treatments to a control. J. Am. Statist. Assoc. 60:573-583.
11. Fisher, R. A. (1934). Statistical Methods for Research Workers. 5th ed. Edinburgh: Oliver and Boyd.
12. Follis, R. H. (1959). Experimental colloid goiter in the hamster. Proc. Soc. Exp. Biol. Med. 100:203-206.
13. Gariot, P., Barrat, E., Mejean, L., Pointel, J. P., Drouin, P., Debry, G. (1983). Fenfibrate and human liver. Lack of proliferation of peroxisomes. Arch. Toxicol. 53:151-163.
14. Goldenthal, E. I., Jessup, D. C., Geil, R. G., Jefferson, N. D., Arceo, R. J. (1978a). Ninety-Day Subacute Rat Study. Study No. 137-085. Mattawan, MI: International Research and Development Corporation.
15. Goldenthal, E. I., Jessup, D. C., Geil, R. G., Mehring, J. S. (1978b). Ninety-Day Subacute Rhesus Monkey Toxicity Study. Study No. 137-092. Mattawan, MI: International Research and Development Corporation.
16. Greaves, P. (1990). Urinary tract. In: Peter, M. B., Greaves, P. eds. Histopathology of Preclinical Toxicity Studies: Interpretation and Relevance in Drug Safety Evaluation. Amsterdam: Elsevier, pp. 497-583.
17. Hansen, K. J., Clemen, L. A., Ellefson, M. E., Johnson, H. O. (2001). Compound-specific, quantitative characterization of organic fluorochemicals in biological matrices. Environ. Sci. Technol. 35:766-770.
18. Haughom, B., Spydevold, O. (1992). The mechanism underlying the hypolipemic effect of perfluorooctanoic acid (PFOA), perfluorooctane sulphonic acid (PFOSA) and clofibric acid. Biochem. Biophys. Acta. 1128:65-72.
19. Hochberg, Y., Tamhane, A. C. (1987). Multiple Comparison Procedures. New York: Wiley, pp. 53-64.
20. Ikeda, T., Fukuda, K., Mori, I., Enomoto, M., Komai, T., Suga, T. (1987). Induction of cytochrome P-450 and peroxisome proliferation in rat liver by perfluorinated octanesulfonic acid. In: Fahimi, H. D., Sies, H., eds. Peroxisomes in Biology and Medicine. New York: Springer Verlag, pp. 304-308.
21. Johnson, J. D., Gibson, S. J., Ober, R. E. (1979). Extent and Route of Excretion and Tissue Distribution of Total Carbon-14 in Rats After a Single i.v. Dose of FC-95-14C. Project No. 8900310200. St. Paul, MN: Riker Laboratories, Inc.
22. Johnson, J. D., Gibson, S. J., Ober, R. E. (1984). Cholestyramine- enhanced fecal elimination of carbon-14 in rats after administration of ammonium [14C] perfluorooctanoate or potassium [14C] perfluorooctanesulfonate. Fundam. Appl. Toxicol. 4(6):972-976.
23. Jonckheere, A. R. (1954). A distribution-free k-sample test against ordered alternatives. Biometrika 41:133-145.
24. Kaminsky, L. S., Mahoney, M. C., Leach, J., Melius, J., Miller, M. J. (1990). Fluoride: benefits and risks of exposure. Crit. Rev. Oral Biol. Med. 1(4):261-281.
25. Kanno, J., Onodera, H., Furuta, K., Maekawa, A., Kasuga, T., Hayashi, Y. (1992). Tumor-promoting effects of both iodine deficiency and iodine excess in the rat thyroid. Toxicol. Pathol. 20:226-235.
26. Kennedy, G. L. Jr. (1985). Dermal toxicity of ammonium perfluorooctanoate. Toxicol. Appl. Pharmacol. 81:348-355.
27. Kennedy, G. L. Jr., Hall, G. T., Brittelli, M. R., Barnes, J. R., Chen, H. C. (1986). Inhalation toxicity of ammonium perfluorooctanoate. F.d. Chem. Toxicol. 24(12):1325-1329.
28. Kissa, E. (2001). Fluorinated surfactants and repellents, revised and expanded. In: Surfactant Science Series. 2nd ed. Vol. 97. Marcel Dekker, Inc.: New York.
29. Levene, H. (1960). Robust tests for equality of variances. In: Olkin, I., ed. Contributions to Probability and Statistics. Palo Alto, CA: Stanford University Press, pp. 278-292.
30. Maurer, J. K., Cheng, M. C., Boysen, B. G., Anderson, R. L. (1990). Two-year carcinogenicity study of sodium fluoride in rats. J. Natl. Cancer Inst. 82:1118-1126.
31. Moody, D. E., Reddy, J. K., Lake, B. G., Popp, J. A., Reese, D. H. (1991). Peroxisome proliferation and nongenotoxic carcinogenesis: commentary on a symposium. Fundam. Appl. Toxicol. 16:233-248.
32. Nabbefeld, J., Butenhoff, J., Bass, N., Seacat, A. (1998). Displacement of a fluorescently labeled fatty acid analogue from fatty acid carrier proteins by Wyeth-14,643, ammonium perfluorooctanoate, potassium perfluorooctane sulfonate and other known peroxisome proliferators. Toxicologist 42:1948.
33. National Research Council (1996). Guide for the Care and Use of Laboratory Animals. Washington, DC: National Academy Press.
34. Nelson, D. G. A., Coote, G. E., Vickridge, I. C., Suckling, G. (1989). Proton microprobe determination of fluorine profiles in the enamel and dentine of erupting incisors from sheep given low and high daily doses of fluoride. Arch. Oral Biol. 34:419-429.
35. Olsen, G. W., Burris, J. M., Mandel, J. H., Zobel, L. R. (1999). Serum perfluorooctane sulfonate and hepatic and lipid clinical chemistry tests in fluorochemical production employees. J. Occup. Environ. Med. 41(9):799-806.
36. Pastoor, T. P., Lee, K. P., Perri, M. A., Gillies, P. J. (1987). Biochemical and morphological studies of ammonium perfluorooctanoate-induced hepatomegaly and peroxisome proliferation. Exp. Mol. Pathol. 47:98-109.
37. Paynter, O. E., Harris, J. E., Burin, G. J., Jaeger, R. B. (1985). Guidance for Analysis of Evaluation of Subchronic Exposure Studies. United States Environmental Protection Agency, EPA-540/9-85-020, EPA-540/9-85-020, Washington, D.C.
38. Perkins, R. G. (1992). Investigation of ammonium perfluorooctanoate effect on hormone levels and peroxisomal proliferation in the rat. Toxicologist 12(1):52.
39. Rao, N. S., Baker, B. E. (1994). Textile finishes and fluorosurfactants. In: Banks, R. E., Smart, B. E., Tatiow, J. C., eds. Organofluorine Chemistry, pp. 321-338.
40. Rao-Rupanagudi, S., Heywood, R., Gopinah, C. (1991). Age-related changes in thyroid structures and function in Sprague-Dawley rats. Vet. Pathol. 29(4):278-287.
41. Reddy, C. S., Hayes, A. W. (1989). Food borne toxicants. In: Hayes, A. W., ed. Principles and Methods of Toxicology. New York: Pergamon Press, pp. 93-94.
42. Selwyn, M. R. (1995). The use of trend tests to determine a no-observable-effect level in animal safety studies. J. Am. Coll. Toxicol. 14(2):158-168.
43. Shapiro, S. S., Wilk, M. B. (1965). An analysis of variance test for normality (complete samples). Biometrika 52:591-611.
44. Sipes, G. I., Gandolfi, A. J. (1991). Biotransformation of toxicants. In: Amdur, M. O., Doull, J., Klaassen, C. D., eds. Casarett and Doull's Toxicology: The Basic Science of Poisons. New York: Pergamon Press, pp. 88-126.
45. Snedcor, G. W., Cochran, W. G. (1967). Statistical Methods. 6th ed. Ames, IA: The Iowa State University Press. pp. 246-248, 349-352.
46. Sohlenius, A. K., Eriksson, A. M., Hogstrom, C., Kimland, M., Depierre, J. W. (1993). Perfluorooctane sulfonic acid is a potent inducer of peroxisomal fatty acid beta-oxidation and other activities known to be affected by peroxisome proliferators in mouse liver. Pharmacol. Toxicol. 72:90-93.
47. Starkov, A. A., Wallace, K. B. (2002). Structural determinants of fluorochemical-induced mitochondrial dysfunction. Toxicol. Sci. 66(2):244-252.
48. 3M Co. Data. Riker Laboratories, Inc. (1980). Extent and Route of Excretion and Tissue: Distribution of Total Carbon-14 in Male and Female Rats After a Single i.v. Dose of FC-143-14C, Drug Metabolism Report 1-20, St. Paul, MN.
49. Tamhane, A. C. (1979). A comparison of procedures for multiple comparison of means with unequal variances. J. Am. Statist. Assoc. 74:471-480.
50. Ubel, F., Sorenson, S., Roach, D. (1980). Health status of plant workers exposed to fluorochemicals: a preliminary report. Am. Ind. Hyg. Assoc. 41:584-589.
51. Vanden Heuvel, J. P. (1999). Peroxisome proliferator-activated receptors (PPARS) and carcinogenesis. Toxicol. Sci. 47:1-8.